233 related articles for article (PubMed ID: 12974944)
21. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
[TBL] [Abstract][Full Text] [Related]
22. Combined intravesical chemotherapy with mitomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study.
Rigatti P; Lev A; Colombo R
Eur Urol; 1991; 20(3):204-10. PubMed ID: 1823044
[TBL] [Abstract][Full Text] [Related]
23. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
Bahouth Z; Halachmi S; Moskovitz B; Nativ O
Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
[TBL] [Abstract][Full Text] [Related]
24. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
25. [Oral tegafur plus mitomycin versus intravesical mitomycin alone in the prevention of recurrence in stage Ta bladder tumors].
Server Pastor G; Rigabert Montiel M; Bañón Pérez V; Valdelvira Nadal P; Cao Avellaneda E; García Hernández JA; Pérez Albacete M
Actas Urol Esp; 2003 Jun; 27(6):438-41. PubMed ID: 12918150
[TBL] [Abstract][Full Text] [Related]
26. Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer.
Wen YC; Lee LM; Lin YW; Syu SH; Lin KH; Fan YC; Lee HL; Lai BCH; Shih HJ
Int J Hyperthermia; 2021; 38(1):1627-1632. PubMed ID: 34775895
[TBL] [Abstract][Full Text] [Related]
27. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
Hori S; Miyake M; Tatsumi Y; Morizawa Y; Nakai Y; Onishi S; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K
Oncol Rep; 2019 Mar; 41(3):1863-1874. PubMed ID: 30628699
[TBL] [Abstract][Full Text] [Related]
28. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
Wajsman Z; Dhafir RA; Pfeffer M; MacDonald S; Block A; Dragone N; Pontes JE
J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
[TBL] [Abstract][Full Text] [Related]
29. Severely contracted bladder following intravesical mitomycin C therapy.
Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
[TBL] [Abstract][Full Text] [Related]
30. [Combined treatment in patients with carcinoma in situ of the urinary bladder using intravesical pirarubicin, irradiation and hyperthermia].
Takechi T; Kawamura M; Nakagawa H; Inatsuki S; Akiyama K; Yano M; Sumiyoshi Y; Mandai K; Moriwaki S; Kataoka M
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2724-7. PubMed ID: 2277223
[TBL] [Abstract][Full Text] [Related]
31. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy.
Erdogar N; İskit AB; Eroglu H; Sargon MF; Mungan NA; Bilensoy E
Int J Pharm; 2014 Aug; 471(1-2):1-9. PubMed ID: 24836669
[TBL] [Abstract][Full Text] [Related]
32. The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.
van der Heijden AG; Hulsbergen-Van de Kaa CA; Witjes JA
World J Urol; 2007 Jun; 25(3):303-8. PubMed ID: 17574492
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous complications of intravesical treatments for bladder cancer: granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy.
Kureshi F; Kalaaji AN; Halvorson L; Pittelkow MR; Davis MD
J Am Acad Dermatol; 2006 Aug; 55(2):328-31. PubMed ID: 16844523
[TBL] [Abstract][Full Text] [Related]
34. Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.
Xylinas E; Kent M; Dabi Y; Rieken M; Kluth LA; Al Hussein Al Awamlh B; Ouzaid I; Pycha A; Comploj E; Svatek RS; Lotan Y; Karakiewicz PI; Holmang S; Shariat SF
Urol Oncol; 2018 Mar; 36(3):89.e1-89.e5. PubMed ID: 29221642
[TBL] [Abstract][Full Text] [Related]
35. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
[TBL] [Abstract][Full Text] [Related]
36. Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression.
Maffezzini M; Campodonico F; Canepa G; Manuputty EE; Tamagno S; Puntoni M
Cancer Chemother Pharmacol; 2014 May; 73(5):925-30. PubMed ID: 24585046
[TBL] [Abstract][Full Text] [Related]
37. Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.
Arends TJ; Falke J; Lammers RJ; Somford DM; Hendriks JC; de Weijert MC; Arentsen HC; van der Heijden AG; Oosterwijk E; Alfred Witjes J
World J Urol; 2015 Oct; 33(10):1411-7. PubMed ID: 25491674
[TBL] [Abstract][Full Text] [Related]
38. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
Irani J
Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
[TBL] [Abstract][Full Text] [Related]
39. Maintenance therapy for superficial bladder cancer.
Baselli EC; Greenberg RE
Oncology (Williston Park); 2001 Jan; 15(1):85-8; discussion 88-91. PubMed ID: 11271984
[TBL] [Abstract][Full Text] [Related]
40. Effects of intravesical chemotherapy and immunotherapy on semen analysis.
Raviv G; Pinthus JH; Shefi S; Mor Y; Kaufman-Francis K; Levron J; Weissenberg R; Ramon J; Madgar I
Urology; 2005 Apr; 65(4):765-7. PubMed ID: 15833524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
